A Serum Metabolite Classifier for the Early Detection of Type 2 Diabetes Mellitus-Positive Hepatocellular Cancer

Type 2 diabetes mellitus (T2DM) has been identified as an independent risk factor for hepatocellular cancer (HCC). However, there are no ideal biomarkers for the surveillance and early detection of HCC in the T2DM population at present. In this study, we aimed to explore novel metabolite biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Lin-Lin, Han, Yi, Pei, Lin, Yue, Zhi-Hong, Liu, Bo-Yu, Cui, Jing-Wen, Jia, Mei, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315765/
https://www.ncbi.nlm.nih.gov/pubmed/35888734
http://dx.doi.org/10.3390/metabo12070610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315765/
https://www.ncbi.nlm.nih.gov/pubmed/35888734
http://dx.doi.org/10.3390/metabo12070610

Ejemplares similares